SKI Market

A+| A| A-|

Indian Indices

Sensex

74,582.98 -1,451.44
( -1.91%)

Global Indices

Nasdaq

46,702.98 -735.30
(-1.55%)

Dow Jones

6,694.68 -102.12
(-1.50%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,300.41 -53.36
(-0.52%)

Forex

USD-INR

91.92 0.02
(0.02%)

EUR-INR

106.58 -0.28
(-0.27%)

GBP-INR

123.39 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Lincoln Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

531633

INE405C01035

357.3529446

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LINCOLN

14.08

1236.64

EPS(TTM)

Face Value()

Div & Yield %

43.85

0.29

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	623.23	580.55	510.31	472.08	422.91	376.09
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	623.23	580.55	510.31	472.08	422.91	376.09
Other Income	22.48	34.42	22.48	10.00	5.74	12.13
Stock Adjustments	-8.84	5.70	4.24	13.57	-3.67	5.86
Total Income	636.87	620.67	537.03	495.65	424.98	394.08
EXPENDITURE :
Raw Materials	282.48	284.04	245.64	232.15	193.26	192.63
Power & Fuel Cost	11.66	11.47	10.25	8.33	7.10	7.57
Employee Cost	112.45	102.90	93.16	79.72	63.20	54.90
Other Manufacturing Expenses	27.93	23.70	19.55	16.61	16.27	14.35
Selling & Administrative Expenses	75.28	60.99	54.50	50.88	50.80	49.58
Miscellaneous Expenses	3.10	3.24	2.28	2.50	1.58	3.54
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	512.90	486.34	425.39	390.18	332.20	322.57
Operating Profit	123.97	134.33	111.65	105.47	92.78	71.50
Interest	1.88	1.46	2.03	1.45	1.55	1.98
Gross Profit	122.09	132.87	109.62	104.02	91.23	69.52
Depreciation	12.90	10.62	9.17	8.09	7.56	5.47
Profit Before Tax	109.19	122.25	100.45	95.93	83.67	64.05
Tax	25.33	25.44	25.97	25.85	21.17	14.72
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.52	3.49	1.59	0.72	0.25	-0.24
Reported Net Profit	82.35	93.30	72.90	69.35	62.25	49.56
Extraordinary Items	1.31	1.07	0.37	0.61	-0.09	-0.03
Adjusted Net Profit	81.04	92.23	72.53	68.74	62.34	49.59
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	-0.62
P & L Balance brought forward	507.46	417.66	348.26	282.41	220.66	170.09
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	4.11	3.50	3.50	3.50	0.50	7.12
P & L Balance carried down	585.70	507.46	417.66	348.26	282.41	211.92
Dividend	0.00	0.00	0.00	0.00	0.00	3.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	18.00	18.00	15.00	15.00	15.00	15.00
Dividend Per Share(Rs)	1.80	1.80	1.50	1.50	1.50	1.50
Earnings Per Share-Unit Curr	41.11	46.58	36.40	34.63	31.08	24.78
Earnings Per Share(Adj)-Unit Curr	41.11	46.58	36.40	34.63	31.08	24.78
Book Value-Unit Curr	335.34	295.98	250.86	216.12	182.92	152.25
Book Value(Adj)-Unit Curr	335.34	295.98	250.86	216.12	182.92	152.25

74,582.98 -1,451.44 ( -1.91%)

46,702.98 -735.30 (-1.55%)

6,694.68 -102.12 (-1.50%)

53,838.16 -614.80 (-1.13%)

10,300.41 -53.36 (-0.52%)

91.92 0.02 (0.02%)

106.58 -0.28 (-0.27%)

123.39 -0.12 (-0.10%)

0.58 0.00 (-0.46%)